Current and historical daily PE Ratio for Aceragen Inc (
STU:V9Z
) from 2013 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aceragen stock (STU:V9Z) PE ratio as of Jun 06 2024 is 0.
More Details
Aceragen Inc (STU:V9Z) PE Ratio (TTM) Chart
Aceragen Inc (STU:V9Z) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1194
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Aceragen PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-06 | At Loss | 2023-11-22 | At Loss |
| 2024-01-25 | At Loss | 2023-11-21 | At Loss |
| 2024-01-24 | At Loss | 2023-11-20 | At Loss |
| 2024-01-23 | At Loss | 2023-11-17 | At Loss |
| 2024-01-22 | At Loss | 2023-11-16 | At Loss |
| 2024-01-19 | At Loss | 2023-11-15 | At Loss |
| 2024-01-18 | At Loss | 2023-11-14 | At Loss |
| 2024-01-17 | At Loss | 2023-11-13 | At Loss |
| 2024-01-16 | At Loss | 2023-11-10 | At Loss |
| 2024-01-12 | At Loss | 2023-11-09 | At Loss |
| 2024-01-11 | At Loss | 2023-11-08 | At Loss |
| 2024-01-10 | At Loss | 2023-11-07 | At Loss |
| 2024-01-09 | At Loss | 2023-11-06 | At Loss |
| 2024-01-08 | At Loss | 2023-11-03 | At Loss |
| 2024-01-05 | At Loss | 2023-11-02 | At Loss |
| 2024-01-04 | At Loss | 2023-11-01 | At Loss |
| 2024-01-03 | At Loss | 2023-10-31 | At Loss |
| 2024-01-02 | At Loss | 2023-10-30 | At Loss |
| 2024-01-01 | At Loss | 2023-10-27 | At Loss |
| 2023-12-29 | At Loss | 2023-10-26 | At Loss |
| 2023-12-28 | At Loss | 2023-10-25 | At Loss |
| 2023-12-27 | At Loss | 2023-10-24 | At Loss |
| 2023-12-25 | At Loss | 2023-10-23 | At Loss |
| 2023-12-22 | At Loss | 2023-10-20 | At Loss |
| 2023-12-21 | At Loss | 2023-10-19 | At Loss |
| 2023-12-20 | At Loss | 2023-10-18 | At Loss |
| 2023-12-19 | At Loss | 2023-10-17 | At Loss |
| 2023-12-18 | At Loss | 2023-10-16 | At Loss |
| 2023-12-15 | At Loss | 2023-10-13 | At Loss |
| 2023-12-14 | At Loss | 2023-10-12 | At Loss |
| 2023-12-13 | At Loss | 2023-10-11 | At Loss |
| 2023-12-12 | At Loss | 2023-10-10 | At Loss |
| 2023-12-11 | At Loss | 2023-10-09 | At Loss |
| 2023-12-08 | At Loss | 2023-10-06 | At Loss |
| 2023-12-07 | At Loss | 2023-10-05 | At Loss |
| 2023-12-06 | At Loss | 2023-10-04 | At Loss |
| 2023-12-05 | At Loss | 2023-10-03 | At Loss |
| 2023-12-04 | At Loss | 2023-10-02 | At Loss |
| 2023-12-01 | At Loss | 2023-09-29 | At Loss |
| 2023-11-30 | At Loss | 2023-09-28 | At Loss |
| 2023-11-29 | At Loss | 2023-09-27 | At Loss |
| 2023-11-28 | At Loss | 2023-09-26 | At Loss |
| 2023-11-27 | At Loss | 2023-09-25 | At Loss |
| 2023-11-24 | At Loss | 2023-09-22 | At Loss |
| 2023-11-23 | At Loss | 2023-09-21 | At Loss |
Aceragen Inc (STU:V9Z) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Aceragen Inc
NAICS : 325414
SIC : 2836
ISIN : US45168K4058
Compare
Compare
Traded in other countries / regions
V9Z.Germany IPO Date
2013-09-26Description
Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers